
Company Info
Year Established2022
Contacts
Bill Yelle, M.S., M.B.A.Co-Founder & CEO
Company Description
FireCyte Therapeutics is a neuroscience-based ophthalmology company developing novel multi-target intravitreal injected proteins that are both anti-inflammatory and neuroprotective for retinal disorders.
